NEW YORK, NY / ACCESSWIRE / January 28, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want ...
Citi lowered the firm’s price target on Regeneron (REGN) to $750 from $795 and keeps a Neutral rating on the shares. Ahead of the Q4 earnings, ...
Msheireb Properties, Qatar's leading smart and sustainable real estate developer, has partnered with Yardi® to elevate its operational efficiency and enhance tenant ...